Disclosing your MS to your employer is an important decision that can sometimes be tricky and can sometimes lead to unintended consequences. Joining me to discuss some of the things you want to be thinking about when it comes to disclosing your MS in the workplace is a Manager on the Benefits, Employment, and Insurance Team at the National MS Society, Christina Forster. 

We're also extending an invitation for you to spend a quick couple of minutes taking the RealTalk MS listener survey...and we're adding some motivation to that invitation by giving you an opportunity to win a $100 Amazon gift card.

And we're inviting you to get up close and personal with some of the most brilliant MS researchers in the world in Part 1 of our two-part special podcast series, Barancik Prize Conversations. 

While we're talking about brilliant MS researchers, we're also revealing this year's recipient of the John Dystel Prize for MS Research.

We'll share some of the details surrounding the partial hold that the FDA has imposed on three different Phase 3 clinical trials for a new category of MS disease-modifying therapy.

We'll tell you about a small clinical trial that demonstrated the benefit of telerehabilitation in improving MS-related bladder problems.

And we'll tell you about an upcoming clinical trial for the first MS disease-modifying therapy to be formulated as a nasal spray.

We have a lot to talk about! Are you ready for RealTalk MS??!

Take the RealTalk MS listener survey...you might win a $100 Amazon gift card!  :22

This Week: Disclosing your MS in the workplace  1:15

Don't miss Part 1 of our special series, Barancik Conversations   2:07

And the winner of the John Dystel Prize for MS Research is...  4:05

The FDA has put a temporary hold on three Phase 3 clinical trials for a new category of MS disease-modifying therapy  5:42

STUDY: Telerehabilitation shown to be successful in managing MS-related bladder problems   8:39

Tiziana Life Scences announces Phase 2 clinical trial for Foralumab, the first MS disease-modifying therapy to be formulated as a nasal spray   12:05

Christina Forster reviews the things you'll want to consider when you're thinking about disclosing your MS to your employer   14:11

Share this episode  30:01

Please remember to take our listener survey!  30:21

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/292

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected] Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Take the RealTalk MS Listener Survey  https://realtalkms.com/survey

RealTalk MS Special Podcast Series: Barancik Prize Conversations Part 1 https://realtalkms.com/barancik1

STUDY: Effects of Pelvic Floor Muscle Training Applied with Telerehabilitation in Patients with Multiple Sclerosis Having Lower Urinary Tract Symptoms: A Randomized Controlled Study https://tandfonline.com/doi/abs/10.1080/07399332.2023.2190593

Take the RealTalk MS Listener Survey  https://realtalkms.com/survey

Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 294 Guests: Christina Forster

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy